±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1216  |  »Ø¸´: 13
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßhappykeren2008½«ÔùËÍÄú 15 ¸ö½ð±Ò
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

happykeren2008

¾èÖú¹ó±ö (ÕýʽдÊÖ)

¿Õ¿ÕµÀÈË

[ÇóÖú] ÎÄÕ¶ÎÂäÖз­Ó¢ÒÑÍê³É£¬»¹Ðè³æÓÑÐÞ¸Ä

ÒÔÏ·­ÒëÐÞ¸Ä15½ð±Ò£º£¨Ó¢ÎIJ¿·ÖµÄÐ޸ģ¬¸Ã²¿·Ö·­ÒëÓÉ11Â¥µÄsdau100 Íê³É£©
µ¥´Î¸øÒ©µÄÄÍÊÜÐÔÊÔÑ飺26Ãû½¡¿µÊÜÊÔÕߣ¬ÄÐÅ®¸÷°ë£¬¸ù¾ÝÌåÖØºÍÐÔ±ðËæ»ú·ÖÅäµ½6¸ö¼ÁÁ¿×飨A×é¡¢B×é¡¢C×é¡¢D×é¡¢E×é¡¢F×飩¡£A×é2ÈË£»B×é¡¢C×éÿ×é4ÈË£¬D×é¡¢E×éÿ×é6ÈË£»F×é4ÈË¡£²ÎÕÕ·ÑÊϵÝÔö·¨£¨¸ÄÁ¼Fibonacci·¨£©µÝÔö¸øÒ©£¬¸÷×é·Ö±ðÍ¿²¼°¬µÏ¿µßòÈé¸à2%¡Á2g¡¢2%¡Á4g¡¢4%¡Á4g¡¢4%¡Á6g¡¢6%¡Á6g¡¢6%¡Á7g¡£Ã¿¸öÊÜÊÔÕßÖ»½ÓÊÜÒ»¸öÏàÓ¦µÄ¼ÁÁ¿£¬´ÓС¼ÁÁ¿¿ªÊ¼£¬Ã¿¸ö¼ÁÁ¿Ó¦Óúóδ¼û²»Á¼·´Ó¦£¬²Å¿ÉÓÃÏÂÒ»¸ö¼ÁÁ¿£¬¹Û²ì¸øÒ©ºó½¡¿µÈËÌå¶Ô°¬µÏ¿µßòÈé¸àµÄ·´Ó¦ºÍÄÍÊÜÐÔ¡£
¶à´Î£¨ÀÛ»ý£©¸øÒ©µÄÄÍÊÜÐÔÊÔÑ飺6Ãû½¡¿µÊÜÊÔÕßÍ¿²¼°¬µÏ¿µßòÈé¸à2%¡Á4g£¬Ã¿ÈÕ1´Î£¬Á¬Ðø7d£¬¹Û²ì¸øÒ©ºó½¡¿µÈËÌå¶Ô°¬µÏ¿µßòÈé¸àµÄ·´Ó¦ºÍÄÍÊÜÐÔ¡£
Ò©´ú¶¯Á¦Ñ§ÊÔÑ飺ѡÔñµ¥´Î¸øÒ©ÄÍÊÜÐÔÊÔÑéÖеÚ2¼ÁÁ¿×飨2%¡Á4g£©µÄ2ÀýÊÜÊÔÕß½øÐÐÔ¤ÊÔÑ飬Èç¼ì²â²»³öѪҩŨ¶È£¬ÔòÑ¡Ôñµ¥´Î¸øÒ©ÄÍÊÜÐÔÊÔÑéÖеÚ3¼ÁÁ¿×飨4%¡Á4g£©µÄ2ÀýÊÜÊÔÕß½øÐÐÔÙ´ÎÔ¤ÊÔÑ飬ÔÙ¸ù¾ÝÔ¤ÊÔÑé½á¹ûÉóºË²¢ÐÞÕýÔ­Éè¼ÆµÄ²ÉÑùµã¡£ÈçÈÔ¼ì²â²»³öѪҩŨ¶È£¬ËµÃ÷°¬µÏ¿µßò»ù±¾²»Í¨¹ýƤ·ôÎüÊÕÈëѪ£¬ÔòÍ£Ö¹µ¥´Î¸øÒ©Ò©´ú¶¯Á¦Ñ§ÊÔÑé¡£
ÔÚ¶à´Î¸øÒ©ÄÍÊÜÐÔÊÔÑéͬʱ½øÐÐÒ©´ú¶¯Á¦Ñ§Ñо¿£¬Ñ¡È¡¶à´Î¸øÒ©ÄÍÊÜÐÔÊÔÑé6ÃûÊÜÊÔÕߣ¬Á¬Ðø¸øÒ©4Ììºó£¬ÔÚµÚ5¡¢6¡¢7Ìì¸øÒ©Ç°²É¼¯ÑªÑù¡¢µÚ7Ìì¸øÒ©ºó²»Í¬Ê±¼ä£¨¸ù¾Ýµ¥´Î¸øÒ©µÄÒ©´ú¶¯Á¦Ñ§ÊÔÑé½á¹ûÈ·¶¨£©²É¼¯ÑªÑù£¬ÓÃLC-MS-MS²â¶¨Ñª½¬Öа¬µÏ¿µßòµÄŨ¶È¡£

Single administration of the Tolerance test: 26 healthy volunteers, men and women account for half of, according to their weight and gender,were randomly assigned to six-dose group (A group, B group, C group, D group, E Group, F Group ). A Group 2; B group, C group four in each, D group, E Group 6 each; F Group 4. The light's incremental costs (modified Fibonacci) increased administration, the groups were coated Andiconazole cream 2% ¡Á 2g, 2% ¡Á 4g, 4% ¡Á 4g, 4% ¡Á 6g, 6% ¡Á 6g, 6% ¡Á 7g. Each of the volunteers only accept a corresponding dose, small doses first, after each dose of no adverse reactions, then the next dose used to observe the response and tolerance the health body may does after given of Andiconazole cream.
Multiple (cumulative) administration's tolerance test: six healthy volunteers were coated Andiconazole cream 2% ¡Á 4g daily, for 7 d, observed the response and tolerance after health body administration of Andiconazole cream.
Pharmacokinetics test: choose a single administration tolerance test in the No. 2-dose group (2% ¡Á 4g) of the two cases pre-trial, If not detected plasma concentration, then choose the two cases No. 3-dose group a single administration the test in (4% ¡Á 4g),to pre-test subjects, according to pre-test results to review and amend the original design of the sampling points. If still not detected plasma concentration ,that may show few Andiconazole cream was absorbed into the blood through the skin, then stop the single administration pharmacokinetics trial.
During the administration tolerance tests,at the same time pharmacokinetics, select multiple administration tolerance test of six volunteers, Continuous administration four days, in section 5, 6, 7 days before delivery collecting blood samples, the 7th days after administration at different times (based on a single administration of the pharmacokinetics test results) collecting blood samples, using LC-MS-MS determinate the Andiconazole concentration in plasma.

[ Last edited by happykeren2008 on 2008-6-3 at 22:05 ]

» ²ÂÄãϲ»¶

ÌÒ֮زز£¬×Æ×ÆÆä»ª¡£Ö®×ÓÓڹ飬ÒËÆäÊÒ¼Ò¡£ÌÒ֮زز£¬ÓÐêÚÓб¦¡£Ö®×ÓÓڹ飬ÒËÆä¼ÒÊÒ¡£ÌÒ֮زز£¬ÆäÒ¶ÝèÝè¡£Ö®×ÓÓڹ飬ÒËÆä¼ÒÈË¡£
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sdau100

ľ³æ (ÕýʽдÊÖ)

ÒýÓûØÌû:
Originally posted by candy-king2008 at 2008-6-3 13:48:
²»¹ýits plasma concentration of Andiconazole also relatively low,Õâ¾ä»°ÊDz»ÊÇȱÉÙÒ»¸öνÓï°¡£¿½¨Òé¸Ä³Éits plasma concentration of Andiconazole was also comparatively low.

¶àлÌáÐÑ

´ó¼Ò¹²Í¬Ñ§Ï°

[ Last edited by sdau100 on 2008-6-3 at 21:53 ]
10Â¥2008-06-03 21:38:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 14 ¸ö»Ø´ð

BigJake

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
happykeren2008(½ð±Ò+30,VIP+0):лл£¡
µÚ¶þ²¿·Ö·­Ò룬½ö¹©²Î¿¼£º
Finally: After single and many times of Adye-Kang-Zuo cream, the volunteers showed no significant responses to the circumference blood, breath, pulse, blood pressure, body temperature and the hepatorenal function and so on. Furthermore, the skin-reaction and the subjective sensation (pain, itches) were not observed after partial medication.
As for 4 healthy volunteers given Adye-Kang-Zuo cream, the dosage of Adye-Kang-Zuo cream was lower than the lowest examination to limit and unable to calculate the medicine generation of dynamics parameter.
As for other 6 healthy volunteers,  individual blood medicine density showed time curve was assumed multi-dosage Adye-Kang-Zuo in vivo and showed the wave shape. Thus, it was also unable with the non-auriculo-ventricular modeling to estimate the medicine generation of dynamics parameter.
Conclusion: This was good in the healthy volunteer tolerance and no obvious side effects were showed. Furthermore, the use margin for safety was wide and the clinical uses might be 2% was acceptable every day (Total less tha 20 g).
2Â¥2008-06-03 03:23:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

BigJake

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

µÚ¶þ²¿·Ö½Ó×Å·­ÒëÈçÏ£¬½ö¹©²Î¿¼£º£¨°¬µÏ¿µßòÈé¸à·­ÒëΪAdye-Kang-Zuo cream¿ÉÄܲ»ÊǺܺ㬽¨ÒéÐÞ¶©£©
After the healthy volunteer spreaded singly Adye-Kang-Zuo cream, The blood plasma concentration of Adye-Kang-Zuo cream was lower than the lowest examination of limit at most samples time. It showed that few Adye-Kang-Zuo cream was absorbed into the blood.
After the healthy volunteer spreaded repetitiously Adye-Kang-Zuo cream, The blood plasma concentration of Adye-Kang-Zuo cream was also lower and it also showed that few Adye-Kang-Zuo cream was absorbed into the blood. Therefore, The Adye-Kang-Zuo cream possibly only operated partially function.
3Â¥2008-06-03 03:48:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

happykeren2008

¾èÖú¹ó±ö (ÕýʽдÊÖ)

¿Õ¿ÕµÀÈË

лл£¬²»´í£¡·¢Ìûºó48Сʱ½«ËÍÄã30¸ö½ð±Ò£¡ÓÐÆäËû³æ×ÓÐÞ¸ÄBigJakeµÄ·­Òë¿ÉÒÔ·ÖÏí20½ð±Ò£¡
ÌÒ֮زز£¬×Æ×ÆÆä»ª¡£Ö®×ÓÓڹ飬ÒËÆäÊÒ¼Ò¡£ÌÒ֮زز£¬ÓÐêÚÓб¦¡£Ö®×ÓÓڹ飬ÒËÆä¼ÒÊÒ¡£ÌÒ֮زز£¬ÆäÒ¶ÝèÝè¡£Ö®×ÓÓڹ飬ÒËÆä¼ÒÈË¡£
4Â¥2008-06-03 10:40:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²»Ó¦Öú È·¶¨»ØÌûÓ¦Öú (×¢Ò⣺ӦÖú²Å¿ÉÄܱ»½±Àø£¬µ«²»ÔÊÐí¹àË®£¬±ØÐëÌîд15¸ö×Ö·ûÒÔÉÏ)
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏ¿ª´óѧ0710ÉúÎïѧ359Çóµ÷¼Á +3 ÍÃÍÃÍÃ111223314 2026-03-29 3/150 2026-03-29 23:14 by Evan_Liu
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Ê¦·¶´óѧÓлú»¯Ñ§×¨Òµ£¬³õÊÔ351·Ö£¬¸´ÊÔ±»Ë¢Çóµ÷¼Á! +5 ÕæÃûÓбù 2026-03-29 6/300 2026-03-29 20:53 by ÌÆãå¶ù
[¿¼ÑÐ] 311Çóµ÷¼Á +6 ¶¬Ê®Èý 2026-03-24 6/300 2026-03-29 20:45 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 275Çóµ÷¼Á +15 Micky11223 2026-03-25 20/1000 2026-03-29 20:44 by ÌÆãå¶ù
[¿¼ÑÐ] 334·Ö Ò»Ö¾Ô¸ÎäÀí ²ÄÁÏÇóµ÷¼Á +7 ÀîÀî²»·þÊä 2026-03-26 7/350 2026-03-29 16:25 by ѧԱ8dgXkO
[¿¼ÑÐ] 375Çóµ÷¼Á +4 ÓêÏÄÕûÒ¹ 2026-03-29 4/200 2026-03-29 12:09 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 085600£¬×¨Òµ¿Î»¯¹¤Ô­Àí£¬321·ÖÇóµ÷¼Á +5 ´ó²öС×Ó 2026-03-28 5/250 2026-03-29 08:56 by qingfeng258
[¿¼ÑÐ] ѧ˶274Çóµ÷¼Á +9 LiÀîÓã 2026-03-26 9/450 2026-03-28 21:42 by bymhappy
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 raojunqi0129 2026-03-28 3/150 2026-03-28 15:27 by ÂäÉ˼
[¿¼ÑÐ] 347Çóµ÷¼Á +3 ɽ¶¥¼û¦Á 2026-03-25 3/150 2026-03-28 14:13 by ÌÆãå¶ù
[¿¼ÑÐ] 317Çóµ÷¼Á +6 Ê®ÏÐwx 2026-03-24 6/300 2026-03-28 13:27 by Iveryant
[¿¼ÑÐ] 081200-314 +3 LILIQQ 2026-03-27 4/200 2026-03-28 09:41 by ±£»¤µØÇòÄãÎÒ×öÆ
[¿¼ÑÐ] ÕÅ·¼Ãú-Öйúũҵ´óѧ-»·¾³¹¤³Ìר˶-298 +4 ÊÖ»úÓû§ 2026-03-26 4/200 2026-03-28 07:17 by mmm just
[¿¼ÑÐ] 333Çóµ÷¼Á +3 questionÍì·ç 2026-03-23 3/150 2026-03-27 11:29 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Çóµ÷¼Á +6 ÁÖ֮Ϧ 2026-03-24 6/300 2026-03-27 08:38 by hypershenger
[¿¼ÑÐ] 336²ÄÁÏÇóµ÷¼Á +7 ³ÂäÞÓ¨ 2026-03-26 9/450 2026-03-27 00:20 by wxiongid
[¿¼ÑÐ] ×Ü·Ö322ÇóÉúÎïѧ/Éú»¯Óë·Ö×Ó/ÉúÎïÐÅϢѧÏà¹Øµ÷¼Á +5 ÐdzÁuu 2026-03-26 6/300 2026-03-26 19:02 by macy2011
[¿¼ÑÐ] 0854µç×ÓÐÅÏ¢Çóµ÷¼Á 324 +4 Promise-jyl 2026-03-23 4/200 2026-03-25 11:36 by Sugarlight
[¿¼ÑÐ] 340Çóµ÷¼Á +5 »°Ã·ÌÇ111 2026-03-24 5/250 2026-03-25 06:53 by ilovexiaobin
[¿¼ÑÐ] 277·ÖÇóµ÷¼Á£¬¿çµ÷²ÄÁÏ +3 ¿¼Ñе÷¼Álxh 2026-03-24 3/150 2026-03-24 13:52 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û